HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rea, T. J. Articles by Pape, M. E. Search for Related Content PubMed PubMed Citation Articles by Rea, T. J. Articles by Pape, M. E. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 35, 1274-1282, Copyright © 1994 by Lipid Research, Inc.

ARTICLES

Rabbit liver apolipoprotein A-I synthesis is under nonparenchymal cell paracrine control

TJ Rea, CL Bisgaier, RB DeMattos and ME Pape
Division of Therapeutics, Parke-Davis Pharmaceutical Research Division, Warner-Lambert, Ann Arbor, MI 48105.

Apolipoprotein A-I (apoA-I), the primary protein of high density lipoprotein, originates from intestine and liver of almost all mammalian species. In contrast to most species, intact rabbit liver is only capable of producing minute amounts of apoA-I mRNA and protein. In this report we demonstrate that purified rabbit hepatic parenchymal cells have apoA-I mRNA levels approximately 50-fold higher than intact liver after 48 h in monolayer culture. Investigations of the differential between in vivo and in vitro expression showed that conditioned media from nonparenchymal cells, a cell population essentially absent in parenchymal cell cultures, inhibited the elevation of apoA-I mRNA in a specific, concentration-dependent, and reversible fashion. Furthermore, at a concentration of nonparenchymal cell-conditioned media that inhibited apoA-I mRNA levels by > 80% compared to control, there were only slight changes in apoB, apoE, LDL receptor, LCAT, 7 alpha-hydroxylase, hepatic lipase, HMG-CoA reductase, and albumin mRNA levels. Metabolic labeling of parenchymal cell secreted proteins with [35S]methionine followed by apoA-I immunoprecipitation revealed that apoA-I synthesis and secretion corresponded to the changes observed for apoA-I mRNA. Initial biochemical characterization of the nonparenchymal cell media revealed that the inhibitory factor was > 30 kDa, heat-stable to 70 degrees C, and still active after urea denaturation and renaturation. These data suggest that, in rabbits, hepatic parenchymal-nonparenchymal communication in the form of a secreted factor may attenuate liver apoA- I expression in vivo.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. Duverger, C. Viglietta, L. Berthou, F. Emmanuel, A. Tailleux, L. Parmentier-Nihoul, B. Laine, C. Fievet, G. Castro, J. C. Fruchart, et al. Transgenic Rabbits Expressing Human Apolipoprotein A-I in the Liver Arterioscler. Thromb. Vasc. Biol., December 1, 1996; 16(12): 1424 - 1429. [Abstract] [Full Text]

				F.-Y. Jin, V. S. Kamanna, M.-Y. Chuang, K. Morgan, and M. L. Kashyap Gemfibrozil Stimulates Apolipoprotein A-I Synthesis and Secretion by Stabilization of mRNA Transcripts in Human Hepatoblastoma Cell Line (Hep G2) Arterioscler. Thromb. Vasc. Biol., August 1, 1996; 16(8): 1052 - 1062. [Abstract] [Full Text]

				N. Azrolan, H. Odaka, J. L. Breslow, and E. A. Fisher Dietary Fat Elevates Hepatic ApoA-I Production by Increasing the Fraction of Apolipoprotein A-I mRNA in the Translating Pool J. Biol. Chem., August 25, 1995; 270(34): 19833 - 19838. [Abstract] [Full Text] [PDF]